SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-24-022034
Filing Date
2024-03-13
Accepted
2024-03-13 11:03:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 13 TO SCHEDULE 13D ea0201723-13da13meyer_altami.htm SC 13D/A 33376
  Complete submission text file 0001213900-24-022034.txt   35065
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Subject) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88281 | Film No.: 24744944
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address
Meyer Thomas (Filed by) CIK: 0001616410 (see all company filings)

Type: SC 13D/A